Second Affiliated Hospital Of Soochow University
Clinical trials sponsored by Second Affiliated Hospital Of Soochow University, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Mushroom-Derived compound joins forces with radiation and immunotherapy to fight advanced cancers Results expected Dec 2026 (estimated)
- New sleep drug aims to help Parkinson's patients get a good Night's rest Results expected Dec 2026 (estimated)
- New cocktail therapy aims to shrink Hard-to-Treat tumors Results expected Feb 2027 (estimated)
- Can magnetic pulses ease Parkinson's pain? new trial investigates Results expected Mar 2027 (estimated)
-
New cocktail therapy aims to shrink Hard-to-Treat tumors
Disease control Not yet recruitingThis phase 2 trial will test a combination of four treatments—cetuximab β (a targeted antibody), radiation, an immunotherapy drug (envafolimab), and a growth factor (GM-CSF)—in 40 adults with advanced solid tumors that have EGFR protein and are no longer responding to standard ca…
Phase 2 • Sponsor: Second Affiliated Hospital of Soochow University • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
Mushroom-Derived compound joins forces with radiation and immunotherapy to fight advanced cancers
Disease control Not yet recruitingThis phase 2 trial tests a combination of PRaG-1 Cordycepin Tablets (from a fungus), radiation therapy, immune-boosting injections, and immunotherapy drugs in 65 adults with advanced solid tumors who have no standard treatment options. The goal is to see if this mix improves immu…
Phase 2 • Sponsor: Second Affiliated Hospital of Soochow University • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
Could a common diabetes drug shield your brain after a stroke?
Disease control Not yet recruitingThis study tests whether a diabetes drug called sentagliptin (a DPP4 inhibitor) can improve thinking and memory in people who have had a mild stroke and also have type 2 diabetes. About 312 participants will receive either the drug or a placebo daily for 180 days. Researchers wil…
Phase 3 • Sponsor: Second Affiliated Hospital of Soochow University • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
New sleep drug aims to help Parkinson's patients get a good Night's rest
Symptom relief Not yet recruitingThis study tests whether dimdazenil, a sleep medication, can safely improve sleep in people with Parkinson's disease who also have insomnia. Researchers will measure sleep changes using overnight brain-wave recordings. The trial involves 50 adults with mild-to-moderate Parkinson'…
Sponsor: Second Affiliated Hospital of Soochow University • Aim: Symptom relief
Last updated Jul 22, 2026 00:00 UTC